Abstract:Background Circular RNA (circRNA), an endogenous non-coding RNA (ncRNA), plays a critical role in gene regulation and shows potential as diagnostic or prognostic biomarkers of human diseases. However, to date there has been little research on the role of circRNAs in the occurrence and development of esophageal cancer. Methods We adopted a three-stage design first using a high-throughput microarray chip to screen for differentially expressed circRNAs in esophageal squamous cell carcinoma (ESCC), then performing a validation study via quantitative reverse transcription polymerase chain reaction (qRT-PCR), and followed by functional analysis using in vitro experiments. In the discovery stage, we screened seven paired samples of ESCC and corresponding adjacent normal-appearing tissues for differentially expressed circRNAs. In the validation stage, we compared the expression of candidate circRNAs in 45 patients with ESCC and 45 healthy controls. In the functional analysis stage, we used three types of cell lines to explore the function of hsa_circ_0030162. Results In the discovery stage, we observed 459 up-regulated and 275 down-regulated differentially expressed circRNAs with FC ≥2.0 and P <0.05. Among these, hsa_circ_0030162 was ranked as the top down-regulated circRNA (FC=12.1). Thus, we selected this circRNA for validation using qRT-PCR and compared its expression in 45 patients with ESCC and 45 healthy controls. If using tissue hsa_circ_0030162 as the diagnostic biomarker, the AUC was 0.743 (95% CI: 0.639-0.848) with a sensitivity of 73.33% and a specificity of 66.67%. If using plasma hsa_circ_0030162 as the diagnostic biomarker, the AUC was 0.735 (95% CI: 0.632-0.837) with a sensitivity of 73.33% and a specificity of 62.22%. The in vitro experiments revealed that hsa_circ_0030162 could promote apoptosis and inhibit proliferation, migration, and invasion of ESCC cells. Luciferase reporter assays proved that it could bind to miR-125a-3p, a non-coding RNA involved in carcinogenesis. Conclusions Our results provide the first evidence that hsa_circ_0030162 plays an important role in the development and progression of ESCC. In addition, we illustrate the diverse roles of hsa_circ_0030162 in regulating cell proliferation, migration, invasion and apoptosis. Based upon our findings, we propose that hsa_circ_0030162 may act as a promising biomarker for clinical diagnosis of ESCC and suggest a new pathway for the development of anti-tumor therapeutics. Funding: The present study was supported by the National Natural Science Foundation of China [81673249], National Key R&361 D Program of China [2017YFC0907000], Social Development Project in Jiangsu Province [BE2015694], Scientific Research Innovation Project for Graduate Students in Jiangsu Province [KYCX17_1293], and Priority Academic Program Development of Jiangsu Higher Education Institutions PAAD]. Declaration of Interest: The authors declare that they have no competing interests. Ethical Approval: This study was approved by the Ethics Committee of Nanjing Medical University. After informed consents from all participants, questionnaires were used to collect demographic data.

Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma

Circular RNA hsa_circ_0000700 promotes cell proliferation and migration in Esophageal Squamous Cell Carcinoma by sponging miR-1229

Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis

Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation

Upregulated circ RNA hsa_circ_0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma

Upregulation of Hsa_circ_0000977 Participates in Esophageal Squamous Cancer Progression by Sponging Mir-874-3p

Hsa_circ_0001707 Regulates Endothelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Via Mir-203A-3p/snail2 Pathway

Splicing Factor ESRP1 Derived Circ_0068162 Promotes the Progression of Oral Squamous Cell Carcinoma Via the Mir-186/Jag Axis.

EIF4A3-mediated oncogenic circRNA hsa_circ_0001165 advances esophageal squamous cell carcinoma progression through the miR-381-3p/TNS3 pathway

Hsa_circrna6448-14 Promotes Carcinogenesis in Esophageal Squamous Cell Carcinoma

Has_Circ_0030162: A Novel Epigenetic Biomarker and Potential Therapeutic Target for Esophageal Carcinoma

Circ_0024108 Promotes the Progression of Esophageal Cancer Cells.

Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis

Circ_0023990 Promotes the Proliferation, Invasion, and Glycolysis of Esophageal Squamous Cell Carcinoma Cells Via Targeting miR-6884-5p/PAK1 Axis

circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR‐155‐5p/FZD5 axis

Circular RNA Circ‐tnrc6b Inhibits the Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells by Regulating the Mir‐452‐5p/dag1 Axis

Identification and Function of Circular RNA Hsa_circ_0071106: A Novel Biomarker for Differentiation Degree of Esophageal Squamous Cell Carcinoma.

Circ_ZNF778_006 promoted ESCC progression by upregulating HIF-1α expression via sponging miR-18b-5p

Circ-ZDHHC5 Accelerates Esophageal Squamous Cell Carcinoma Progression in vitro via miR-217/ZEB1 Axis

Circ_0072088 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Cancer by Absorbing miR-377

Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway